For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251113:nRSM4188Ha&default-theme=true
RNS Number : 4188H Home REIT PLC 13 November 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE
A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
13 November 2025
Home REIT plc
("HOME" or the "Company")
Response to press speculation
The Board of Home REIT notes the recent press speculation concerning the
Company's portfolio sales process and confirms that the Company has entered
into an exclusivity agreement with Patron Capital in respect of the disposal
of the majority of the Company's portfolio of assets.
In addition, the Board notes the speculation concerning the indicative terms
of the proposed disposal. Although the terms of the disposal are not yet
finalised, the Company confirms that the indicated price is £123.0 million
for approximately 700 of the Company's 853 properties. The remaining
properties in the Company's portfolio were valued at £18.25 million in the
draft valuation report prepared by Jones Lang LaSalle as at 31 August 2025.
While discussions are ongoing with Patron Capital, there can be no certainty
that a transaction will be agreed upon or as to the final terms of any such
agreement, and this update should not be construed as announcing a
transaction.
The Board is committed to maximising value for shareholders and will provide a
further update when appropriate. The sales process is expected to conclude in
Q4 2025 or early 2026.
The person responsible for arranging the release of this announcement on
behalf of the Company is Apex Group.
FOR FURTHER INFORMATION, PLEASE CONTACT:
FTI Consulting (Communications Adviser) HomeREIT@fticonsulting.com (mailto:HomeREIT@fticonsulting.com)
Dido Laurimore +44 (0)20 3727 1000
Bryn Woodward
Oliver Harrison
The Company's LEI is: 213800A53AOVH3FCGG44.
For more information, please visit the Company's website: www.homereituk.com
(http://www.homereituk.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END SPCPKNBPFBDKADD
Copyright 2019 Regulatory News Service, all rights reserved